Sources | Names Used |
---|---|
CTRPv2 | BRD-A02303741:navitoclax (2:1 mol/mol) |
PharmacoGx | BRD-A02303741:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | HIST2H3D | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | MARCH11 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
mRNA | PNO1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | CDC7 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | BARHL1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | GLUD2 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
mRNA | STOML2 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | GALNT16 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | SSR2 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | DPM3 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |